Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Halts Gardasil Lobbying Efforts Following Discussions With ACIP, AAP

Executive Summary

Merck decided to halt lobbying efforts for state legislation requiring vaccination with its human papilloma virus vaccine Gardasil for school entry following discussions with third party stakeholders, including CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics, the company said
Advertisement

Related Content

HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?
HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says
Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says
Merck Ups Marketing Spend For Januvia And Gardasil As Competitors Stumble
Gardasil Reimbursement Issues To Be Resolved In Early 2007, Merck Says
Gardasil Clears FDA, But Dosing May Pose Administrative Challenges
Gardasil Clears FDA, But Dosing May Pose Administrative Challenges
Advertisement
UsernamePublicRestriction

Register

PS048079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel